Eli Lilly and Co DRC (LLY)

CBOE Canada
Currency in CAD
32.46
+1.08(+3.44%)
Closed

LLY Income Statement

Advanced Income Statement
Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa24,539.828,318.428,541.434,124.145,042.7
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+9.95%+15.4%+0.79%+19.56%+32%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa5,483.36,973.16,629.87,082.28,418.3
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa19,056.521,345.321,911.627,041.936,624.4
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+8.29%+12.01%+2.65%+23.41%+35.44%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa77.66%75.38%76.77%79.25%81.31%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa11,845.713,072.613,258.316,254.619,584.4
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa+2.13%+10.36%+1.42%+22.6%+20.49%
aa.aaaa.aaaa.aaaa.aaaa.aa5,976.36,930.77,190.89,313.410,990.6
aa.aaaa.aaaa.aaaa.aaaa.aa5,869.46,141.96,067.56,941.28,593.8
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa7,210.88,272.78,653.310,787.317,040
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+20.19%+14.73%+4.6%+24.66%+57.96%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa29.38%29.21%30.32%31.61%37.83%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-326.6-314.4-268.8-312.3-605.4
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-2%+3.74%+14.5%-16.18%-93.85%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-359.6-339.8-331.6-485.9-605.4
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa3325.462.8173.6-
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-195.551.4-14.3-32.7386.8
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa6,688.78,009.78,370.210,442.316,821.4
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-749.8-2,018.1-1,130.1-3,822-4,141
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa7,229.96,155.56,806.46,554.612,680.4
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+37.3%-14.86%+10.57%-3.7%+93.46%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa29.46%21.74%23.85%19.21%28.15%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa1,036.2573.8561.61,314.22,090.4
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa6,193.75,581.76,244.85,240.410,590
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa6,193.75,581.76,244.85,240.410,590
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-25.54%-9.88%+11.88%-16.08%+102.08%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa25.24%19.71%21.88%15.36%23.51%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa6,193.75,581.76,244.85,240.410,590
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa6.826.156.935.8211.71
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+36.99%-9.81%+12.53%-15.94%+101.22%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa6.796.126.95.811.71
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+36.9%-9.87%+12.75%-15.94%+101.9%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa907.63906.96901.74900.18904.06
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa912.51911.68904.62903.28904.06
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa2.963.43.924.525.2
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+14.73%+14.86%+15.29%+15.31%+15.04%
EBITDA
aa.aaaa.aaaa.aaaa.aa